Opposite influences of hypertension and diabetes mellitus on pressor responses induced by different α-adrenoceptor agonists and angiotensin II in pithed rats

Blood Pressure

Volumn 5, Issue 1, 1996, Pages 57-63

  Beenen, O H M ^a   Mathy, M J ^a   Pfaffendorf, M ^a   Van Zwieten, P A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Angiotensin II; Diabetes mellitus; Hypertension; Pithed rats; adrenoceptor agonists

Indexed keywords

2 (2 CHLORO 5 TRIFLUOROMETHYLPHENYLIMINO)IMIDAZOLIDINE; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANGIOTENSIN; AZEPEXOLE; BRIMONIDINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STREPTOZOCIN DIABETES;

EID: 0029939032     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.3109/08037059609062107     Document Type: Article

References (44)

1. Tomlinson KC, Gardiner SM, Hebden RA, Bennett T. Functional consequences of streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system. Pharmacol Rev 1992; 44: 103-50.
2. Mulvany MJ. Structure and function of small arteries in hypertension [Review]. J Hypertens 1990; Suppl 8: S225-32.
3. Mulvany MJ. The fourth Sir George Pickering memorial lecture. The structure of the resistance vasculature in essential hypertension [Review]. J Hypertens 1987; 5: 129-36.
4. King GL, Shiba T, Oliver J, Inoguchi T, Bursell SE. Cellular and molecular abnormalities in the vascular endothelium of diabetes mellitus [Review]. Ann Rev Med 1994; 45: 179-88.
5. Mulvany MJ. Changes to the vascular system resulting from hypertension and their effects on response to therapy [Review]. Drugs 1990; 39 Suppl 1: 9-20.
6. Owen MP, Carrier GO. Calcium dependence of norepinephrine-induced vascular contraction in experimental diabetes. J Pharmacol Exp Ther 1980; 212: 253-8
7. Abebe W, Harris KH, MacLeod KM. Enhanced contractile responses of arteries from diabetic rats to alpha 1-adrenoceptor stimulation in the absence and presence of extracellular calcium. J Cardiovasc Pharmacol 1990; 16: 239-48.
8. Harris KH, MacLeod KM. Influence of the endothelium on contractile responses of arteries from diabetic rats. Eur J Pharmacol 1988; 153: 55-64.
9. Christ GJ, Valcic M, Gondre MC, Augmentation in the kinetic characteristics of phenylephrine-and 5-hydroxytryptamine-induced contractions in the isolated rat aorta following eight weeks of STZ-diabetes. Life Sci 1994; 55: 807-14.
10. Chang KC, Chung SY, Chong WS, et al. Possible superoxide radical-induced alteration of vascular reactivity in aortas from streptozotocin-treated rats. J Pharmacol Exp Ther 1993; 266: 992-1000.
11. Fortes ZB, Garcia Lerne J, Scivoletto R, Vascular reactivity in diabetes mellitus: role of the endothehal cell. Br J Pharmacol 1983; 79: 771-81.
12. Agrawal DK, McNeill JH. Vascular responses to agonists in rat mesenteric artery from diabetic rats. Can J Physiol Pharmacol 1987; 65: 1484-90.
13. Abebe W, MacLeod KM. Protein kinase C-mediated contractile responses of arteries from diabetic rats. Br J Pharmacol 1990; 101: 465-71.
14. Lucas PD. Effects of streptozotocin-induced diabetes and noradrenaline infusion on cardiac output and its regional distribution in pithed rats. Diabetologia 1985; 28: 108-12.
15. Heijnis JB, Mathy M-J, Pfaffendorf M, van Zwieten PA. Differential effects of alpha 1- and alpha 2-adrenoceptor agonists on peripheral vasoconstriction in pithed diabetic rats. J Cardiovasc Pharmacol 1992; 20: 554-8.
16. Jackson CV, Carrier GO. Influence of short-term experimental diabetes on blood pressure and heart rate in response to norepinephrine and angiotensin II in the conscious rat. J Cardiovasc Pharmacol 1983; 5: 260-5.
17. Christlieb AR, Janka HU, Kraus B, et al. Vascular reactivity to angiotensin II and to norepinephrine in diabetic subjects. Diabetes 1976; 25: 268-74.
18. Lograno MD, Daniele E, Vulpis V, Pirrelli A. Calcium channels in the vascular smooth muscle of spontaneously hypertensive rats. J Hypertens 1993; 11 (Suppl 5): S124-5.
19. Jie K, Van Brummelen P, Vermey P, Timmermans PBMWM, van Zwieten PA. Alpha 1- and alpha 2-adrenoceptor mediated vasoconstriction in the forearm of normotensive and hypertensive subjects. J Cardiovasc Pharmacol 1986; 8: 190-6.
20. Dohi Y, Criscione L, Pfeiffer K, Lüscher TF. Angiotensin blockade or calcium antagonists improve endothelial dysfunction in hypertension: studies in perfused mesenteric resistance arteries. J Cardiovasc Pharmacol 1994; 24: 372-9.
21. Panza JA, Quyyumi AA, Brush JE Jr., Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22-7.
22. Bruning TA, Chang PC, Hendriks MGC, Vermey P, Pfaffendorf M, van Zwieten PA. In vivo characterization of muscarinic receptor subtypes that mediate vasodilatation in patients with essential hypertension. Hypertension 1995; 26: 70-7.
23. Hendriks MGC, Kam KL, Pijl AJ, Pfaffendorf M, van Zwieten PA. The effects of hypertension and diabetes on the vascular reactivity of resistance arteries. Blood Pressure 1993; 2: 69-76.
24. Epstein M, Sowers JR, Diabetes mellitus and hypertension [Review]. Hypertension 1992; 19: 403-18.
25. Vallance P, Calver A, Collier J. The vascular endothelium in diabetes and hypertension [Review]. J Hypertens 1992; Suppl 10: S25-9.
26. Hsueh WA, Anderson PW. Hypertension, the endothelial cell, and the vascular complications of diabetes mellitus [clinical conference] [Review]. Hypertension 1992; 20: 253-63.
27. Kam KL, Pfaffendorf M, van Zwieten PA. Druginduced endothelium-dependent and -independent relaxations in isolated resistance vessels taken from simultaneously hypertensive and streptozotocin-diabetic rats. Blood Pressure 1994; 3: 418-27.
28. Agrawal DK, McNeill JH. Effect of diabetes on vascular smooth muscle function in normotensive and spontaneously hypertensive rat mesenteric artery. Can J Physiol Pharmacol 1987; 65: 2274-80.
29. Timmermans PBMWM, Thoolen MJ, Mathy M-J, Wilffert B, de Jonge A, van Zwieten PA. Sgd 101/75 is distinguished from other selective alpha 1-adrenoceptor agonists by the inhibition of its pressor responses by calcium entry blockade and vasodilatation in pithed rats and cats. Eur J Pharmacol 1983; 96: 187-92.
30. Timmermans PBMWM, Mathy M-J, Wilffert B, et al. Differential effect of calcium entry blockers on alpha 1-adrenoceptor-mediated vasoconstriction in vivo. Naunyn-Schmiedeberg's Arch Pharmacol 1983; 324: 239-45.
31. Vollmer RR, Meyers-Schoy SA, Marinelli RR. Mechanisms involved in angiotensin II induced increases in cardiac output in pithed rats. Clin Exp Hypertens A 1991; 13: 1433-45.
32. Yamamoto J. Blood pressure and metabolic effects of streptozotocin in wistar kyoto and spontaneously hypertensive rats. Clin Exp Hypertens A 1988; 10: 1065-83.
33. Susic D, Mandai AK, Jovovic DJ, Radujkovic G, Kentera D. Streptozotocin-induced diabetes mellitus lowers blood pressure in spontaneously hypertensive rat. Clin Exp Hypertens A 1990; 12: 1021-35.
34. Beenen OHM, Pfaffendorf M, van Zwieten PA. Contractile responses to various inotropic agents in isolated hearts obtained from hypertensive diabetic rats. Blood Pressure 1995; (In Press).
35. Hebden RA, Gardiner SM, Bennett T, MacDonald IA. The influence of streptozotocin-induced diabetes mellitus on fluid and electrolyte handling in rats. Clin Sci 1986; 70: 111-7.
36. Brown L, Sernia C. Angiotensin receptors in cardiovascular diseases [Review]. Clin Exp Pharmacol Physiol 1994; 21: 811-8.
37. Airaksinen KE, Salmela PI, Linnaluoto MK, Ikaheimo MJ, Ahola K, Ryhanen LJ. Diminished arterial elasticity in diabetes: association with fluorescent advanced glycosylation end products in collagen. Cardiovasc Res 1993; 27: 942-5.
38. Kubota I, Fukuhara T, Kinoshita M. Permeability of small coronary arteries and myocardial injury in hypertensive diabetic rats. Int J Cardiol 1990; 29: 349-55.
39. Yamamoto J, Nakai M. Effects of moderate diabetes on cardiac performance in spontaneously hypertensive and wistar kyoto rats. Hypertension 1988; 11: 344-51.
40. Yamamoto J, Nakai M. Coronary hemodynamics in diabetic spontaneously hypertensive rats. Clin Exp Hypertens A 1990; 12: 325-42.
41. Scarborough NL, Carrier GO. Nifedipine and alpha adrenoceptors in rat aorta. II. Role of extracellular calcium in enhanced alpha-2 adrenoceptor-mediated contraction in diabetes. J Pharmacol Exp Ther 1984; 231: 603-9.
42. Lais LT, Brody MJ. Vasoconstrictor hyperresponsiveness: an early pathogenic mechanism in the spontaneously hypertensive rat. Eur J Pharmacol 1978; 47: 177-89.
43. van Zwieten PA, Safar M et al. New insights into the role of endothelial dysfunction in hypertension. J Hypertens 1995; 13: 713-6.
44. Linder L, Kiowski W, Bühler FR, Lüscher TF. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension. Circulation 1990; 81: 1762-7.